Position
Squarepoint Ops LLC in Intellia Therapeutics, Inc.
Back to the book · All holders of NTLA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $546.7K$8.99 → $12.82
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 142.7K | $1.28M | — | — | — | 0.0% |
| Q1 2026 | 210K | $2.69M | $12.82 | $546.7K | $862.1K | 0.0% |